Isolation of CYP3A4 Inhibitors from the Black Cohosh (Cimicifuga racemosa)
- PMID: 15937564
- PMCID: PMC1142198
- DOI: 10.1093/ecam/neh086
Isolation of CYP3A4 Inhibitors from the Black Cohosh (Cimicifuga racemosa)
Abstract
Recent investigation on drug interaction has shown that some foods and herbal medicines increase the oral availability of a variety of CYP3A4 substrates, which is caused by the reduction of CYP3A4 in intestinal epithelium. During the course of our investigation on CYP3A4 interaction, we found that the commercially available dietary supplement made from black cohosh (Cimicifuga racemosa) showed CYP3A4 inhibition. Black cohosh has been used for the treatment of menopausal and post-menopausal symptoms as a dietary supplement. Bioassay-guided isolation from the supplement afforded six active principles, which were identified as cycloartanoid triterpene glycosides.
Figures
Similar articles
-
In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh).Chem Res Toxicol. 2003 Jul;16(7):838-46. doi: 10.1021/tx020108n. Chem Res Toxicol. 2003. PMID: 12870886 Clinical Trial.
-
Muscle damage induced by black cohosh (Cimicifuga racemosa).Phytomedicine. 2006 Jan;13(1-2):115-8. doi: 10.1016/j.phymed.2004.09.002. Epub 2005 Jun 24. Phytomedicine. 2006. PMID: 16360941
-
Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms - comments on major statements of the Cochrane Collaboration report 2012 "black cohosh (Cimicifuga spp.) for menopausal symptoms (review)".Gynecol Endocrinol. 2013 Dec;29(12):1022-5. doi: 10.3109/09513590.2013.831836. Epub 2013 Sep 2. Gynecol Endocrinol. 2013. PMID: 23992293
-
[Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms--review of clinical trials].Ginekol Pol. 2008 Apr;79(4):287-96. Ginekol Pol. 2008. PMID: 18592868 Review. Polish.
-
United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity.Menopause. 2008 Jul-Aug;15(4 Pt 1):628-38. doi: 10.1097/gme.0b013e31816054bf. Menopause. 2008. PMID: 18340277 Review.
Cited by
-
Cytochrome P450 enzyme mediated herbal drug interactions (Part 2).EXCLI J. 2014 Aug 20;13:869-96. eCollection 2014. EXCLI J. 2014. PMID: 26417310 Free PMC article. Review.
-
Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin.J Clin Pharmacol. 2006 Feb;46(2):201-13. doi: 10.1177/0091270005284854. J Clin Pharmacol. 2006. PMID: 16432272 Free PMC article. Clinical Trial.
-
Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database.Sci Rep. 2022 Aug 19;12(1):14178. doi: 10.1038/s41598-022-17704-z. Sci Rep. 2022. PMID: 35986023 Free PMC article.
-
Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics.Evid Based Complement Alternat Med. 2017;2017:5929234. doi: 10.1155/2017/5929234. Epub 2017 Nov 14. Evid Based Complement Alternat Med. 2017. PMID: 29348769 Free PMC article. Review.
-
Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro.Curr Drug Saf. 2010 Apr;5(2):118-24. doi: 10.2174/157488610790936150. Curr Drug Saf. 2010. PMID: 20406160 Free PMC article.
References
-
- New Medicinal College of Jiangsu (ed.). Shanghai: Shanghai Scientific and Technological Press; 1977. Dictionary of Chinese Materia Medica; p. 451.
-
- Lieberman S. A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J Women's Health. 1998;7:525–29. - PubMed
-
- McKenna D, Jones K, Humphrey S, Hughes K. Black cohosh: efficacy, safety, and use in clinical and preclinical applications. Altern Ther. 2001;7:93–100. - PubMed
-
- Borrelli F, Izzo AA, Ernst E. Pharmacological effects of Cimicifuga racemosa. Life Sci. 2003;73:1215–29. - PubMed
-
- Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 1996;6:1–42. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources